Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

EMD 61753

Known as: EMD 61 753, EMD-61 753, EMD-61753 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1999
Highly Cited
1999
The objective of the present study was to evaluate the effects of EMD 61753 (asimadoline), a kappa-opioid receptor agonist with… Expand
Is this relevant?
1996
1996
Several heterocyclic bicyclo[3.3.1]nonan‐9‐ones were found to have a high affinity to k opioid receptors. 3,7… Expand
Is this relevant?
1995
1995
EMD 61753 (N-methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl) -ethyl ]- 2,2-diphenyl-acetamide hydrochloride) is a… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
1 The pharmacological properties of the novel diarylacetamide k‐opioid receptor agonist, EMD 61753, have been compared with those… Expand
Is this relevant?